Katelyn Kiel, CPA

Katelyn Kiel, CPA, has a diverse work experience spanning multiple years. Katelyn is currently working as the Associate Director of Financial Planning & Analysis at Xilio Therapeutics, Inc. since April 2022. Prior to this, Katelyn held various roles at Biogen, including Senior Manager of Medical Finance from January 2021 to April 2022, Senior Manager of IT & Commercial Finance from September 2019 to January 2021, Manager of R&D Finance & Accounting from February 2018 to September 2019, and Senior Analyst of Accounting from June 2016 to February 2018.

Before joining Biogen, Katelyn worked at Deloitte & Touche LLP as an Audit Senior from September 2014 to June 2016. Katelyn also served in various positions at Deloitte, including Audit Senior Assistant from September 2013 to August 2014, and Audit Assistant from September 2012 to August 2013.

Katelyn began their career as an Audit Intern at Deloitte in June 2011. Prior to that, they gained experience as an Accounting/Finance Intern at Kronos from June 2010 to August 2010. Throughout their career, Katelyn has demonstrated their expertise in finance and accounting, particularly in the pharmaceutical industry.

Katelyn Kiel, CPA obtained a Bachelor of Arts (B.A.) degree in Accounting from the College of the Holy Cross, where they studied from 2008 to 2012. In October 2013, they also obtained the Certified Public Accountant (CPA) certification from the Massachusetts Board of Public Accountancy.